Mark Gross is a distinguished Partner at Downing LLP, where he serves as the Head of Development Capital and plays a pivotal role as a senior member of the investment team. With over two decades of experience in private equity, Mark has honed his expertise...
Mark Gross is a distinguished Partner at Downing LLP, where he serves as the Head of Development Capital and plays a pivotal role as a senior member of the investment team. With over two decades of experience in private equity, Mark has honed his expertise in private equity origination, structuring, execution, and investment management. His leadership has been instrumental in driving key projects that focus on management buyouts (MBOs) and growth and development investments, particularly within the healthcare sector. Under his guidance, Downing LLP has successfully managed over £2 billion in funds, positioning the firm as a significant player in the UK investment landscape.
Mark's accolades, including being named the Lead Investor in the HealthInvestor Power50 for 2023 and winning the HealthInvestor Private Equity Investor of the Year in 2020, underscore his exceptional track record in identifying and capitalizing on lucrative investment opportunities. His strategic vision and deep understanding of the market dynamics have enabled him to navigate complex financial restructurings, leverage finance, and real estate investments effectively.
In addition to his investment acumen, Mark is a skilled Non-Executive Director, contributing valuable insights to portfolio management and mergers and acquisitions. His commitment to fostering growth and development in the sectors he invests in reflects Downing LLP's unifying theme of supporting sustainable business models. With a keen eye for emerging trends and a robust network within the industry, Mark Gross continues to shape the future of private equity investment, driving innovation and value creation for stakeholders.
